Pages that link to "Q42554027"
Jump to navigation
Jump to search
The following pages link to Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers (Q42554027):
Displaying 50 items.
- HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response (Q21090490) (← links)
- DNA immunization as a technology platform for monoclonal antibody induction (Q26751432) (← links)
- HIV-1 neutralizing antibodies: understanding nature's pathways (Q27000480) (← links)
- Synthetic DNA vaccine strategies against persistent viral infections (Q27016078) (← links)
- Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model (Q27345320) (← links)
- Sang Froid in a time of trouble: is a vaccine against HIV possible? (Q27487961) (← links)
- Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets (Q28742787) (← links)
- In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers (Q28744555) (← links)
- Human immunodeficiency virus vaccine trials (Q30424366) (← links)
- HIV-1 vaccine development after STEP. (Q33642318) (← links)
- Novel directions in HIV-1 vaccines revealed from clinical trials (Q33645528) (← links)
- DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice. (Q33647708) (← links)
- Identifying Stabilizers of Plasmid DNA for Pharmaceutical Use (Q33673230) (← links)
- Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines. (Q33698142) (← links)
- Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments (Q33713435) (← links)
- Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies (Q33749827) (← links)
- Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. (Q33759392) (← links)
- Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice (Q33818084) (← links)
- HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. (Q33869332) (← links)
- Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer (Q34059543) (← links)
- Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus (Q34120140) (← links)
- New approaches to design HIV-1 T-cell vaccines (Q34274849) (← links)
- A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates. (Q34444535) (← links)
- Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations (Q34641666) (← links)
- Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies (Q34982715) (← links)
- Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge (Q35087579) (← links)
- Clinical applications of DNA vaccines: current progress (Q35452312) (← links)
- Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion (Q35558828) (← links)
- DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection (Q35758746) (← links)
- Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. (Q35826610) (← links)
- Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. (Q36114395) (← links)
- Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants (Q36119504) (← links)
- Strategies for eliciting HIV-1 inhibitory antibodies (Q36452155) (← links)
- Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease (Q36616505) (← links)
- Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates (Q36694846) (← links)
- Designing tomorrow's vaccines (Q36730618) (← links)
- CryJ-LAMP DNA Vaccines for Japanese Red Cedar Allergy Induce Robust Th1-Type Immune Responses in Murine Model (Q36901422) (← links)
- Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine (Q36977750) (← links)
- Technical transformation of biodefense vaccines (Q37058898) (← links)
- T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces (Q37333743) (← links)
- Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001 (Q37409262) (← links)
- Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1) (Q37530471) (← links)
- DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus. (Q37530479) (← links)
- DNA immunization (Q37576264) (← links)
- The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility. (Q37667754) (← links)
- Principles of vaccine design-Lessons from nature (Q37780346) (← links)
- Neutralizing antibodies and control of HIV: moves and countermoves. (Q37971867) (← links)
- Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo (Q37996192) (← links)
- Improved outlook on HIV-1 prevention and vaccine development (Q38009870) (← links)
- The design and evaluation of HIV-1 vaccines (Q38019332) (← links)